Browsing by Author Cequier Fillat, Àngel R.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 32 to 36 of 36 < previous 
Issue DateTitleAuthor(s)
Apr-2022Safety and efficacy of the supreme biodegradable polymer sirolimus-eluting stent in patients with diabetes mellitusThomas, Alexander; Kereiakes, Dean J.; Baumbach, Andreas; Windecker, Stephan; Pietras, Cody; Dressler, Ovidiu; Issever, M. Ozgu; Curtis, Michael; Bertolet, Barry; Zidar, James P.; Smits, Pieter C.; Jimenez Díaz, Victor Alfonso; McLaurin, Brent; Cequier Fillat, Àngel R.; Takahashi, Akihiko; Cannon, Louis A.; Amoroso, Giovanni; Kakuta, Tsunekazu; Saito, Shigeru; Leon, Martin B.; Lansky, Alexandra J.
18-Sep-2015The MGuard coronary stent: safety, efficacy, and clinical utilityGracida Blancas, Montserrat; Romaguera, Rafael; Jacobi, Francisco; Gómez Hospital, Joan Antoni; Cequier Fillat, Àngel R.
7-Dec-2018Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)Katagiri, Yuki; Onuma, Yoshinobu; Asano, Taku; Iñiguez Romo, Andres; Jensen, Lisette Okkels; Cequier Fillat, Àngel R.; Hofma, Sjoerd H.; Christiansen, Evald H.; Suttorp, Maarten; Brugaletta, Salvatore; Räber, Lorenz; Sabaté Tenas, Manuel; Windecker, Stephan; Serruys, Patrick W.
5-Jan-2012Thrombin-receptor antagonist vorapaxar in acute coronary syndromesTricoci, Pierluigi; Cequier Fillat, Àngel R.; Held, Claes; Moliterno, David J.; Armstrong, Paul W.; Ambrosio, Giuseppe; Leonardi, Sergio
8-Mar-2016Variabilidad Farmacodinámica en la Respuesta a Clopidogrel: Mecanismos Implicados y Uso de Inhibidores Más Potentes del Receptor Plaquetario P2Y12 en Pacientes con Enfermedad CoronariaFerreiro Guitiérrez, José Luis